What does CUSIP 29664W105 represent in this 13F holders report?

CUSIP 29664W105 is the security identifier for ESPR - Esperion Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held ESPR - Esperion Therapeutics, Inc. - COM in Q1 2017?

116 institutional investors reported ESPR - Esperion Therapeutics, Inc. - COM for Q1 2017. Use the holders table for investor-level position and value details.

Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / COM
Shares outstanding: 258,506,508
Total 13F shares: 17,982,623
Share change: +4,444,907
Total reported value: $634,962,044
Put/Call ratio: 341%
Price per share: $35.31
Number of holders: 116
Value change: +$201,687,554
Number of buys: 75
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 29664W105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Pentwater Capital Management LP	13F	Company	0.71%	1,828,000	$22,887,000	—	31 Dec 2016	13F
Aisling Capital LLC	13F	Company	0.63%	1,637,125	$20,497,000	—	31 Dec 2016	13F
BB BIOTECH AG	13F	Company	0.51%	1,308,542	$16,383,000	—	31 Dec 2016	13F
DISCOVERY CAPITAL MANAGEMENT, LLC / CT	13F	Company	0.4%	1,042,046	$13,046,000	—	31 Dec 2016	13F
BlackRock Fund Advisors	13F	Company	0.31%	789,210	$9,881,000	—	31 Dec 2016	13F
FMR LLC	13F	Company	0.3%	766,009	$9,590,000	—	31 Dec 2016	13F
BVF INC/IL	13F	Company	0.28%	712,770	$8,924,000	—	31 Dec 2016	13F
CREDIT SUISSE AG/	13F	Company	0.27%	695,365	$8,706,000	—	31 Dec 2016	13F
VANGUARD GROUP INC	13F	Company	0.23%	600,832	$7,522,000	—	31 Dec 2016	13F
WASATCH ADVISORS LP	13F	Company	0.21%	538,194	$6,738,000	—	31 Dec 2016	13F
NORTHERN TRUST CORP	13F	Company	0.2%	506,512	$6,341,000	—	31 Dec 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.15%	398,499	$4,989,000	—	31 Dec 2016	13F
SENZAR ASSET MANAGEMENT, LLC	13F	Company	0.14%	364,000	$4,557,000	—	31 Dec 2016	13F
Rhenman & Partners Asset Management AB	13F	Company	0.11%	275,000	$3,443,000	—	31 Dec 2016	13F
Granahan Investment Management, LLC	13F	Company	0.1%	248,030	$3,105,000	—	31 Dec 2016	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.09%	239,054	$2,993,000	—	31 Dec 2016	13F
STATE STREET CORP	13F	Company	0.09%	238,482	$2,989,000	—	31 Dec 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.08%	196,500	$2,460,000	—	31 Dec 2016	13F
J. Goldman & Co LP	13F	Company	0.06%	162,000	$2,028,000	—	31 Dec 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	129,084	$1,616,000	—	31 Dec 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	121,060	$1,514,000	—	31 Dec 2016	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.05%	116,480	$1,458,000	—	31 Dec 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	110,523	$1,384,000	—	31 Dec 2016	13F
Tekla Capital Management LLC	13F	Company	0.04%	102,800	$1,287,000	—	31 Dec 2016	13F
PAULSON & CO. INC.	13F	Company	0.04%	102,000	$1,277,000	—	31 Dec 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.04%	97,617	$1,222,000	—	31 Dec 2016	13F
Bank of New York Mellon Corp	13F	Company	0.03%	80,863	$1,012,000	—	31 Dec 2016	13F
MORGAN STANLEY	13F	Company	0.03%	80,086	$1,003,000	—	31 Dec 2016	13F
Quantitative Investment Management, LLC	13F	Company	0.03%	71,900	$900,000	—	31 Dec 2016	13F
GAM Holding AG	13F	Company	0.02%	64,000	$801,000	—	31 Dec 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.02%	59,959	$751,000	—	31 Dec 2016	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.01%	29,555	$666,000	—	31 Dec 2016	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.02%	50,711	$635,000	—	31 Dec 2016	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	49,983	$626,000	—	31 Dec 2016	13F
UBS Group AG	13F	Company	0.02%	48,419	$606,000	—	31 Dec 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	45,651	$572,000	—	31 Dec 2016	13F
PDT Partners, LLC	13F	Company	0.02%	44,900	$562,000	—	31 Dec 2016	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	43,800	$548,000	—	31 Dec 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	42,229	$529,000	—	31 Dec 2016	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	40,220	$504,000	—	31 Dec 2016	13F
Bellevue Group AG	13F	Company	0.02%	40,000	$501,000	—	31 Dec 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	38,910	$487,000	—	31 Dec 2016	13F
Nationwide Fund Advisors	13F	Company	0.01%	38,365	$480,000	—	31 Dec 2016	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.01%	35,280	$442,000	—	31 Dec 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	33,502	$419,000	—	31 Dec 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	31,270	$392,000	—	31 Dec 2016	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.01%	29,651	$371,000	—	31 Dec 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	29,416	$368,000	—	31 Dec 2016	13F
FT Options LLC	13F	Company	0.01%	29,193	$365,000	—	31 Dec 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.01%	24,796	$310,000	—	31 Dec 2016	13F

Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q1 2017

As of 31 Mar 2017, Esperion Therapeutics, Inc. - COM (ESPR) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,982,623 shares. The largest 10 holders included Pentwater Capital Management LP, BB BIOTECH AG, FMR LLC, BlackRock Inc., Boxer Capital, LLC, CREDIT SUISSE AG/, Aisling Capital LLC, PINNACLE ASSOCIATES LTD, WASATCH ADVISORS INC, and VANGUARD GROUP INC. This page lists 116 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders

Q1 2017 holders

116

Holder diff

Investor	Q4 2016 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q4 2016 Value $	Q1 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.